Characteristics of prescription and nonprescription sleep medication users in the United States

Population Health Management

Volumn 17, Issue 6, 2014, Pages 345-350

  Vaidya, Varun ^a   Gabriel, Meghan Hufstader ^b   Gangan, Nilesh ^a   Borse, Mrudula ^c  

^a UNIVERSITY OF TOLEDO   (United States)

^b Office of Health Information Technology Adoption   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG; PRESCRIPTION DRUG;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DRUG USE; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICALLY UNINSURED; PRESCRIPTION; PREVALENCE; RETROSPECTIVE STUDY; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP MEDICINE; UNEMPLOYMENT; UNITED STATES; AGE; DRUG UTILIZATION; INFORMATION PROCESSING; MIDDLE AGED; SLEEP INITIATION AND MAINTENANCE DISORDERS; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; SLEEP INITIATION AND MAINTENANCE DISORDERS; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84918562141     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2013.0124     Document Type: Article

References (38)

1. Institute of Medicine Committee on Sleep Medicine and Research. Sleep disorders and sleep deprivation: an unmet public health problem. Washington, DC: National Academies Press, 2006.
2. Morgan K, Clarke D. Risk factors for late-life insomnia in a representative general practice sample. Br J Gen Pract 1997; 47(416):166-169.
3. Buysse DJ. Insomnia. JAMA 2013;309:706-716.
4. Tamanna S, Geraci SA. Major sleep disorders among women: (women's health series). South Med J 2013;106: 470-478.
5. Sasai T, Inoue Y, Komada Y, Nomura T, Matsuura M, Matsushima E. Effects of insomnia and sleep medication on health-related quality of life. Sleep Med 2010;11:452-457.
6. Wilson SJ, Nutt DJ, Alford C, et al. British Association for Psychopharmacology consensus statement on evidencebased treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 2010;24:1577-1601.
7. Phillips B, Mannino DM. Do insomnia complaints cause hypertension or cardiovascular disease? J Clin Sleep Med 2007;3:489-494.
8. Knutson KL, Ryden AM, Mander BA, Van Cauter E. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 2006;166:1768-1774.
9. Walsh JK. Clinical and socioeconomic correlates of insomnia. J Clin Psychiatry 2004;65 (suppl 8):13-19.
10. Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 2007;30:873-880.
11. Morin AK, Jarvis CI, Lynch AM. Therapeutic options for sleep-maintenance and sleep-onset insomnia. Pharmacotherapy 2007;27(1):89-110.
12. Russo A MK, Marder W. Prescription sleep aid use in young adults. Thomson Reuters Research Brief. 2008. < http://img.en25.com/Web/ThomsonReuters/ResearchBriefSleep AidPharma.pdf >. Accessed June 21, 2013.
13. Komada Y, Nomura T, Kusumi M, et al. Correlations among insomnia symptoms, sleep medication use and depressive symptoms. Psychiatry Clin Neurosci 2011;65(1): 20-29.
14. Neutel CI, Patten SB. Sleep medication use in Canadian seniors. Can J Clin Pharmacol 2009;16:e443-e452.
15. Chong Y, Fryer CD, Gu Q. Prescription sleep aid use among adults: United States, 2005-2010. NCHS Data Brief 2013;(127):1-8.
16. Vaidya V, Partha G, Howe J. Utilization of preventive care services and their effect on cardiovascular outcomes in the United States. Risk Manag Healthc Policy 2011;4:1-7.
17. Kiley JP. Insomnia research and future opportunities. Sleep 1999;22(suppl 2):S344-S345.
18. Goodwin RD, Hasin DS. Sedative use and misuse in the United States. Addiction 2002;97:555-562.
19. Bartlett DJ, Marshall NS, Williams A, Grunstein RR. Predictors of primary medical care consultation for sleep disorders. Sleep Med 2008;9:857-864.
20. Simon GE, Von Korff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997;154: 1417-1423.
21. Cirignotta F. Insomnia: an epidemiological survey. Clin Neuropharmacol 1985;8(suppl 1):S49-S54.
22. Vaidya V, Partha G, Karmakar M. Gender differences in utilization of preventive care services in the United States. J Womens Health (Larchmt) 2012;21:140-145.
23. Brook RH, Kamburg CJ, Mayer-Oakes A, Beers MH, raube K, Steiner A. Appropriateness of acute medical care for the elderly: an analysis of the literature. Health Policy 1990;14: 225-242.
24. Linjakumpu T, Hartikainen S, Klaukka T, Koponen H, Kivelä SL, Isoaho R. Psychotropics among the homedwelling elderly-increasing trends. Int J Geriatr Psychiatry 2002;17:874-883.
25. Spore D, Mor V, Larrat EP, Hiris J, Hawes C. Regulatory environment and psychotropic use in board-and-care facilities: results of a 10-state study. J Gerontol A Biol Sci Med Sci 1996;51(3):M131-M141.
26. Mahmoudi E, Jensen GA. Exploring disparities in access to physician services among older adults: 2000-2007. J Gerontol B Psychol Sci Soc Sci 2013;68(1):128-138.
27. Lau M, Lin H, Flores G. Racial/ethnic disparities in health and health care among U.S. adolescents. Health Serv Res 2012;47:2031-2059.
28. Chen Y-Y, Kawachi I, Subramanian SV, Acevedo-Garcia D, Lee Y-J. Can social factors explain sex differences in insomnia? Findings from a national survey in Taiwan. J Epidemiol Community Health 2005;59:488-494.
29. Zhang J, Lam SP, Li SX, et al. Long-term outcomes and predictors of chronic insomnia: A prospective study in Hong Kong Chinese adults. Sleep Med 2012;13:455-462.
30. Sateia MJ, Doghramji K, Hauri PJ, Morin CM. Evaluation of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 2000;23:243-308.
31. Riedel N, Fuks K, Hoffmann B, et al. Insomnia and urban neighbourhood contexts-are associations modified by individual social characteristics and change of residence? Results from a population-based study using residential histories. BMC Public Health 2012;12:810.
32. Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 2007;30:873-880.
33. Chiu HF-K. The prevalence of sleep problems and their socio-demographic and clinical correlates in young Chinese rural residents. Psychiatry Res 2012;200:789-794.
34. Castro LS, Castro J, Hoexter MQ, et al. Depressive symptoms and sleep: a population-based polysomnographic study. Psychiatry Res 2013;210:906-912.
35. Luca A, Luca M, Calandra C. Sleep disorders and depression: brief review of the literature, case report, and nonpharmacologic interventions for depression. Clin Interv Aging 2013;8:1033-1039.
36. Szelenberger W. [The two-process model of sleep regulation of Alexander Borbély]. Psychiatria Polska 1987;21: 490-494.
37. Santos Moraes WA, Burke PR, Coutinho PL, et al. Sedative antidepressants and insomnia. Rev Bras Psiquiatr 2011; 33(1):91-95.
38. Hershman DL, Simonoff PA, Frishman WH, Paston F, Aronson MK. Drug utilization in the old old and how it relates to self-perceived health and all-cause mortality: results from the Bronx Aging Study. J Am Geriatr Soc 1995;43:356-360.